381 |
Atenção farmacêutica ao paciente portador de asma e Doença Pulmonar Obstrutiva Crônica: coletânea de estudos sobre adesão, uso de inaladores, sistematização da atenção e perfil farmacoepidemiológico / Pharmaceutical care program for patients with asthma and COPD: study collection of adhesion treatment, use of inhalers, systematization of care and pharmacoepidemiological profileSimões, Letícia Zambelli 23 November 2015 (has links)
Introdução: A asma e a DPOC são doenças crônicas inflamatórias que afetam a qualidade de vida dos pacientes. O tratamento medicamentoso é feito, em sua maioria, por via inalatória utilizando para isso os dispositivos inalatórios. O uso incorreto dos dispositivos inalatórios diminui a eficácia dos medicamentos, o que pode ocasionar a não aderência dos pacientes ao tratamento. Vários tipos de programas educativos para asma e DPOC têm sido desenvolvidos, diferenciando-se quanto à forma de abordagem, à situação em que a doença é atendida e aos desfechos considerados. O farmacêutico por meio de um programa educacional pode orientar os pacientes sobre a técnica correta dos dispositivos inalatórios e auxiliar este paciente na adesão ao tratamento. Objetivos: Realizar a compilação e sistematização dos resultados dos trabalhos apresentados pelo programa de atenção farmacêutica aos pacientes asmáticos e portadores de DPOC do ICHC FMUSP e do programa de pós-graduação de Fisiopatologia Experimental. Método: estudo retrospectivo e descritivo dos trabalhos de conclusão dos alunos do Curso de Aprimoramento Profissional em Farmácia Hospitalar e Introdução a Farmácia Clínica da Divisão de Farmácia do ICHC FMUSP e do programa de pós-graduação de Fisiopatologia Experimental da Faculdade de Medicina da USP. Estes estudos desenvolveram a temática da atenção farmacêutica e educação em asma e em DPOC, apresentados entre os anos de 2004 a 2012 que não tiveram artigos ou capítulos de livros publicados. Resultados: Foram enviados três capítulos para publicação no livro Atenção Farmacêutica - Gestão e Prática do HCFMUSP e um artigo será publicado no Jornal Brasileiro de Pneumologia. Conclusão: Publicações acadêmicas com o tema atenção farmacêutica ao paciente portador de doenças respiratórias crônicas demonstram a importânica da orientação/ educação desses pacientes quanto ao tratamento de suas doenças respiratórias / Introduction: Asthma and COPD are chronic inflammatory diseases that affect the quality of life of patients. Drug treatment is done mostly by inhalation, using for it inhalation devices. Incorrect use of inhalers decreases the effectiveness of medications which can cause non-adherence of patients to treatment. Various types of educational programs for asthma and COPD have been developed, differing on the mode the approach, the situation in which the disease is answered and the outcomes considered. The pharmacist through an educational program can educate patients about the proper technique of inhalation devices and assisting the patient to adhere to treatment. Objectives: Perform the compilation and systematization from studies data submitted by the pharmaceutical care program for patients with asthma and COPD developed by pharmacists from course of improvement of the Division of Pharmacy ICHC USP and also by the program of graduate Experimental Pathophysiology, Faculty of Medicine, USP. Method: A retrospective, descriptive study with the outcomes of studies of the students that completed the course in Professional Development Course in Hospital Pharmacy and Introduction to Clinical Pharmacy, of Division of Pharmacy of ICHC USP and the program graduate in Experimental Pathophysiology, Faculty of Medicine of USP. The studies show the theme of pharmaceutical care and asthma education and COPD, submitted between the years 2004 to 2012 and who had no articles or book chapters related books published. Results: three book chapters were sent for publication in the book Pharmaceutical Care - Management and Practice HC FMUSP and one article will be published in the Brazilian Journal of Pulmonology. Conclusion: academic publications on the theme pharmaceutical care to patients with chronic respiratory diseases shows the importance orientation/education of patients regarding the treatment of their respiratory diseases
|
382 |
A depressão e a adesão ao tratamento da infecção pelo HIV (vírus da imunodeficiência humana) / The depression and the adherence to the treatment of the infection of HIV (human immunodeficiency virus)Silva, José Renato da 29 June 2005 (has links)
A epidemia da Síndrome da Imunodeficiência Adquirida (aids) já atingiu aproximadamente 40 milhões de indivíduos em todo o mundo. O controle adequado da infecção pelo HIV através do tratamento anti-retroviral proporciona menor resistência viral, níveis mais baixos de carga viral, diminuindo, assim, a probabilidade da transmissão do HIV. A adesão ao tratamento anti-retroviral é importante para o sucesso do tratamento. A depressão é um transtorno psiquiátrico com prevalência elevada na população geral e nos portadores do HIV/Aids. Sabe-se que a depressão é um fator limitante para boa adesão. Neste trabalho, estudou-se a associação entre a adesão e a depressão em 164 pacientes portadores do HIV/Aids, em acompanhamento médico num serviço especializado, no período de outubro de 2002 a outubro de 2003. Foram aplicados os seguintes instrumentos: SCID/DSM-IV (Strutured Clinical Interview/Diagnostic and Statistical Manual of Mental Disorders), HAM-D (Hamilton Rating for Depression), MMSE (MiniMental State Examination - Miniexame do Estado Mental), questionário sócio-demográfico, laboratorial, da doença e tratamento e questionário de adesão. A média de idade foi 39 anos, e 72% da amostra eram do sexo masculino. Mais de 85% dos pacientes se infectaram com o HIV através de relações sexuais. Apenas 7,9% eram usuários de drogas injetáveis. A média de CD4 foi 404,8 e carga viral 3,55 (log). A prevalência de depressão atual foi 17,7%, com diferença estatisticamente significante entre os mais jovens. Setenta e cinco pacientes (45,73%) apresentaram episódio depressivo passado. Dos 164 pacientes, 137 faziam uso de anti-retrovirais. Pacientes que tomavam 95% dos anti-retrovirais foram considerados pacientes que aderiram ao tratamento. A adesão foi avaliada através de questionário e 79,56% dos pacientes aderiram ao tratamento. A adesão foi maior entre os homens e os mais velhos. A carga viral também apresentou associação com a adesão e com antecedente pessoal de depressão. A adesão não mostrou associação com depressão / Approximately 40 million individuals are infected by HIV/acquired immunodeficiency syndrome (AIDS) in the word. The control of the HIV infection by the antiretroviral treatment provides lower viral resistance; lower viral load levels and diminishes the probability of the transmission of the HIV. The adherence to antiretroviral treatment is important for the success of the treatment. Depression is a psychiatric disorder with high prevalence in general population and in HIV/AIDS infected patients. Depression seems to be a limitation for good adherence. In this study, the association between adherence and depression was assessed in 164 HIV/AIDS infected patients in a specialized service, in the period of October of 2002 and October of 2003. The following instruments were applied: SCID/DSM-IV (Structured Clinical Interview/Diagnostic and Manual Statistical of Mental Disorders), HAM-D (Hamilton Rating for Depression), MMSE (MiniMental State Examination), sociodemographic, laboratorial, disease and adherence questionnaires. The mean age was 39 years-old and 72% of the sample were men. More than 85% of the patients were infected by sexual contact and 7.9% were injecting drug users. The mean of CD4 was 404.8 and viral load 3.55 (log). The prevalence of current depression was 17.7%, with higher prevalence among youngest. Seventy five patients (45.73%) had a lifetime depressive episode. Of the 164 patients, 137 were treated with antiretroviral. Patients who took at least 95% of the antiretroviral medications had been considered adhered to treatment. The adherence was evaluated through questionnaire and was presented in 79.56% of the patients. The adherence was higher among men and oldest. The viral load also showed association with adherence and lifetime depression. The adherence was not associated to depression
|
383 |
Experiences of diabetes mellitus patients who are on treatment at the Piggs Peak Hospital in SwazilandChikwanha, Darlingtone January 2014 (has links)
The aim of this study was to explore and describe the experiences of diabetes mellitus patients at the Piggs Peak Hospital in Swaziland, from the time of diabetes diagnosis to living with diabetes, adherence to treatment and implementing diabetes self-care. A descriptive, exploratory, contextual qualitative research was conducted.
Data was gathered through semi-structured interviews with 26 participants purposively selected on diabetes days at the hospital. Data was analysed qualitatively. Results revealed that patients present late for diagnosis. Being diagnosed causes psychological distress of varying intensity and duration. Hospital visits are burdensome due to financial and transport challenges, as well as service
shortcomings. Self-care activities are difficult due to financial challenges and nonconducive social circumstances at home. Social support is lacking. Diabetes patients fear insulin use and prefer oral tablets. It is concluded that diabetes self-care is burdensome for most patients of the PPH in Swaziland. The service providers, stakeholders, and government need to explore strategies for mitigating effects of
various barriers to self-care as revealed in this study. / Health Studies / M.A. (Public Health)
|
384 |
A depressão e a adesão ao tratamento da infecção pelo HIV (vírus da imunodeficiência humana) / The depression and the adherence to the treatment of the infection of HIV (human immunodeficiency virus)José Renato da Silva 29 June 2005 (has links)
A epidemia da Síndrome da Imunodeficiência Adquirida (aids) já atingiu aproximadamente 40 milhões de indivíduos em todo o mundo. O controle adequado da infecção pelo HIV através do tratamento anti-retroviral proporciona menor resistência viral, níveis mais baixos de carga viral, diminuindo, assim, a probabilidade da transmissão do HIV. A adesão ao tratamento anti-retroviral é importante para o sucesso do tratamento. A depressão é um transtorno psiquiátrico com prevalência elevada na população geral e nos portadores do HIV/Aids. Sabe-se que a depressão é um fator limitante para boa adesão. Neste trabalho, estudou-se a associação entre a adesão e a depressão em 164 pacientes portadores do HIV/Aids, em acompanhamento médico num serviço especializado, no período de outubro de 2002 a outubro de 2003. Foram aplicados os seguintes instrumentos: SCID/DSM-IV (Strutured Clinical Interview/Diagnostic and Statistical Manual of Mental Disorders), HAM-D (Hamilton Rating for Depression), MMSE (MiniMental State Examination - Miniexame do Estado Mental), questionário sócio-demográfico, laboratorial, da doença e tratamento e questionário de adesão. A média de idade foi 39 anos, e 72% da amostra eram do sexo masculino. Mais de 85% dos pacientes se infectaram com o HIV através de relações sexuais. Apenas 7,9% eram usuários de drogas injetáveis. A média de CD4 foi 404,8 e carga viral 3,55 (log). A prevalência de depressão atual foi 17,7%, com diferença estatisticamente significante entre os mais jovens. Setenta e cinco pacientes (45,73%) apresentaram episódio depressivo passado. Dos 164 pacientes, 137 faziam uso de anti-retrovirais. Pacientes que tomavam 95% dos anti-retrovirais foram considerados pacientes que aderiram ao tratamento. A adesão foi avaliada através de questionário e 79,56% dos pacientes aderiram ao tratamento. A adesão foi maior entre os homens e os mais velhos. A carga viral também apresentou associação com a adesão e com antecedente pessoal de depressão. A adesão não mostrou associação com depressão / Approximately 40 million individuals are infected by HIV/acquired immunodeficiency syndrome (AIDS) in the word. The control of the HIV infection by the antiretroviral treatment provides lower viral resistance; lower viral load levels and diminishes the probability of the transmission of the HIV. The adherence to antiretroviral treatment is important for the success of the treatment. Depression is a psychiatric disorder with high prevalence in general population and in HIV/AIDS infected patients. Depression seems to be a limitation for good adherence. In this study, the association between adherence and depression was assessed in 164 HIV/AIDS infected patients in a specialized service, in the period of October of 2002 and October of 2003. The following instruments were applied: SCID/DSM-IV (Structured Clinical Interview/Diagnostic and Manual Statistical of Mental Disorders), HAM-D (Hamilton Rating for Depression), MMSE (MiniMental State Examination), sociodemographic, laboratorial, disease and adherence questionnaires. The mean age was 39 years-old and 72% of the sample were men. More than 85% of the patients were infected by sexual contact and 7.9% were injecting drug users. The mean of CD4 was 404.8 and viral load 3.55 (log). The prevalence of current depression was 17.7%, with higher prevalence among youngest. Seventy five patients (45.73%) had a lifetime depressive episode. Of the 164 patients, 137 were treated with antiretroviral. Patients who took at least 95% of the antiretroviral medications had been considered adhered to treatment. The adherence was evaluated through questionnaire and was presented in 79.56% of the patients. The adherence was higher among men and oldest. The viral load also showed association with adherence and lifetime depression. The adherence was not associated to depression
|
385 |
Treatment of cardiovascular risk factors in type 2 diabetes time trends and clinical practice /Fhärm, Eva, January 2010 (has links)
Diss. (sammanfattning) Umeå : Umeå universitet, 2010. / Härtill 4 uppsatser.
|
386 |
Travel – a risk factor for disease and spread of antibiotic resistanceAngelin, Martin January 2015 (has links)
As international travel is rapidly increasing, more people are being exposed to potentially more antibiotic resistant bacteria, a changed infectious disease epidemiology, and an increased risk of accidents and crime. Research-based advice is needed to adequately inform travellers about these risks. We studied travellers who sought advice from the Travel Medicine Clinic at the Department of Infectious Diseases, Umeå University Hospital, as well as university students from Umeå, Stockholm, and Gothenburg travelling abroad for study, research, and clinical exchange programs. From retrospective data at the Travel Medicine Clinic, we found that pre-existing health problems were rare among travellers from Umeå seeking pre- travel health advice and vaccinations. In addition, we found that the travel destination and the sex of the traveller affected vaccination levels. Although hepatitis A is endemic to both Thailand and Turkey, compared to travellers to Thailand few travellers to Turkey visited the clinic for hepatitis A vaccination. The data also revealed that more women than men were vaccinated against Japanese encephalitis despite comparable trips. A prospective survey study showed that travellers felt that the pre-travel health advice they received was helpful. Two-thirds of the travellers followed the advice given although they still fell ill to the same extent as those who were not compliant with the advice. Factors outside the control of travellers likely affect the travel-related morbidity. Compared to older travellers, younger travellers were less compliant with advice, fell ill to a greater extent, and took greater risks during travel. In a prospective survey study, we found that healthcare students had higher illness rates and risk exposure when abroad compared to students from other disciplines. This difference was mainly due to the fact that healthcare students more often travelled to developing regions during their study period abroad. When abroad, half of all students increased their alcohol consumption and this was linked to an increased risk of theft and higher likelihood of meeting a new sex partner. The healthcare students participating in the survey study also submitted stool samples before and after travel. These samples were tested for the presence of antibiotic resistance, both by selective culturing for ESBL-PE (Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae) as well as by metagenomic sequencing. About one-third (35%) of the students became colonised by ESBL-PE following their study abroad. The strongest risk factor for colonisation was travel destination; for example, 70% of students who had travelled to India became colonised. Antibiotic treatment during travel was also a significant risk factor for colonisation. The stool samples from a subset of study subjects were analysed using metagenomic sequencing. From this we learned that although the majority of resistance genes in the gut microbiome remained unchanged following travel, several clinically important resistance genes increased, most prominently genes encoding resistance to sulphonamide, trimethoprim, and beta-lactams. Overall, taxonomic changes associated with travel were small but the proportion of Proteobacteria, which includes several clinically important bacteria (e.g., Enterobacteriaceae), increased in a majority of the study subjects. Clearly, there are risks associated with international travel and these risks include outside factors as well as the personal behaviour of travellers. We believe our results can be used to develop better pre-travel advice for tourists as well as university students studying abroad resulting in safer travel.
|
387 |
Stimmungsverändernde Medikamente aus Sicht von Arzt und Patient / Attitudes of general practitioners and patients about mood modifying medicinesMeyer, Christoph 18 October 2005 (has links)
No description available.
|
388 |
Diary cards: Preliminary evaluation of an intervention tool for improving adherence to antiretroviral therapy and TB preventive therapy in people living with HIV/AIDS.Roux, Susanna Magrieta January 2004 (has links)
Adherence to prescribed medications is a central feature of good clinical HIV care and a key factor in determining the effectiveness of treatment. This is especially true for HIV-infected patients, on antiretroviral treatment, where adherence is strongly associated with survival. HIV-associated tuberculosis is a major and increasing health problem, especially in sub-Saharan Africa. Clinical trials have demonstrated a benefit of isoniazid preventive therapy in preventing TB among HIV-infected persons, and its use among these patients is recommended. Nearly perfect compliance seems to be indispensable to obtain the maximum benefit from highly active antiretroviral treatment and prophylactic medications. Accurately assessing non-adherence is a necessary first step towards improving adherence to active antiretroviral treatment and isoniazid preventive therapy. The introduction of diary cards is being considered as a measure of adherence and as a tool to improve adherence among HIV-infected individuals receiving antiretroviral treatment or isoniazid preventive therapy. This was a preliminary study to evaluate the effectiveness of diary cards as intervention tool for promoting adherence to antiretroviral and prophylactic TB therapy in people living with HIV/AIDS, to evaluate the diary card as a tool to measure adherence and to evaluate the feasibility and acceptability of diary cards.
|
389 |
Factors that affect adherence to antiretroviral therapy among adolescent patients at selected Palapye clinicsKambale, Herve Nzereka 03 1900 (has links)
Thesis (MPhil)--Stellenbosch University, 2013. / ENGLISH ABSTRACT: This study, which was conducted from 1 to 31 October 2012, was aimed at describing the main factors that influence adolescent adherence to antiretroviral treatment in three selected health facilities of Palapye Health District. During the one-month data collection period, 30 adolescents were interviewed using semi-structured interview tools.
Different factors influencing adolescent adherence to antiretroviral treatment were highlighted and adherence to such treatment was measured using the method of calculating the percentage of returned pills. The mean adherence level for the entire sample was 76.96%, with common factors contributing to poor adherence among adolescents being found to be the poor processing of disclosure, stigma, the accessibility of health facilities, due distance and waiting time, the nature of social support, and feelings toward taking antiretroviral. Thus, by addressing adolescent adherence to antiretroviral treatment, adolescent-adherence counselling before and during treatment is to be shaped, insisting on the preparation of young patient caregivers for the process of disclosure; the reinforcement of positive messages during consultations; insistence on the importance of disclosing HIV status to others; the implementation of the antiretroviral dispensing outreach at health posts; and exerting effort to reduce the waiting time at health facilities prioritising young patients and adolescents. / AFRIKAANSE OPSOMMING: Hierdie studie, wat vanaf 1 tot 31 Oktober 2012 onderneem is, het ten doel gehad om die hooffaktore te beskryf wat adolessente se getrouheid met antiretrovirale behandeling in drie gekose gesondheidsfasiliteite in die Palapye-gesondheidsdistrik beïnvloed. Semigestruktureerde onderhoude is gedurende die maand lange datainsamelingstydperk met 30 adolessente gevoer.
Die studie dui op verskillende faktore wat adolessente se getrouheid met antiretrovirale behandeling beïnvloed, welke getrouheid gemeet is aan die hand van die persentasie teruggestuurde pille. Die gemiddelde getrouheidsvlak vir die algehele steekproef was 76,96%. Algemene faktore wat oënskynlik tot swak behandelingsgetrouheid onder adolessente bydra, is die swak verwerking van MIV-statusonthulling, stigma, die toeganklikheid van gesondheidsfasiliteite, reisafstand en wagtyd, die aard van maatskaplike steun, en gevoelens oor die gebruik van antiretrovirale middels. Hierdie ondersoek na adolessente se getrouheid met antiretrovirale behandeling behoort adolessentberading oor behandelingsgetrouheid voor én gedurende behandeling te rig. Die klem moet in die besonder val op die voorbereiding van die versorgers van jong pasiënte om die onthullingsproses beter te hanteer; die versterking van positiewe boodskappe gedurende konsultasies; die belang van MIV-statusonthulling aan ander; die inwerkingstelling van uitreikaksies om voorskrifte vir antiretrovirale middels by sogenaamde ‘gesondheidstasies’ te resepteer, en daadwerklike pogings om die wagtyd by gesondheidsfasiliteite te verkort, met voorrang aan jong pasiënte en adolessente.
|
390 |
Diary cards: Preliminary evaluation of an intervention tool for improving adherence to antiretroviral therapy and TB preventive therapy in people living with HIV/AIDS.Roux, Susanna Magrieta January 2004 (has links)
Adherence to prescribed medications is a central feature of good clinical HIV care and a key factor in determining the effectiveness of treatment. This is especially true for HIV-infected patients, on antiretroviral treatment, where adherence is strongly associated with survival. HIV-associated tuberculosis is a major and increasing health problem, especially in sub-Saharan Africa. Clinical trials have demonstrated a benefit of isoniazid preventive therapy in preventing TB among HIV-infected persons, and its use among these patients is recommended. Nearly perfect compliance seems to be indispensable to obtain the maximum benefit from highly active antiretroviral treatment and prophylactic medications. Accurately assessing non-adherence is a necessary first step towards improving adherence to active antiretroviral treatment and isoniazid preventive therapy. The introduction of diary cards is being considered as a measure of adherence and as a tool to improve adherence among HIV-infected individuals receiving antiretroviral treatment or isoniazid preventive therapy. This was a preliminary study to evaluate the effectiveness of diary cards as intervention tool for promoting adherence to antiretroviral and prophylactic TB therapy in people living with HIV/AIDS, to evaluate the diary card as a tool to measure adherence and to evaluate the feasibility and acceptability of diary cards.
|
Page generated in 0.0967 seconds